Open Access
Table 4
Effective half-lives of radionuclides considered in this study.
| Radionuclide | Effective half-life considered (days) | Reference |
|---|---|---|
| phosphorus-32 | 14.3 (physical half-life) | – |
| strontium-89 | 50.7 (physical half-life) | – |
| yttrium-90 | 2.7 (physical half-life) | – |
| indium-111 | 0.6 | (Jones, 2004) |
| iodine-131: Thyroid non-cancer MIBG Lipiocis® Thyroid cancer |
5.2 2.0 5.5 0.9 |
(Jones, 2004; U.S. NRC, 2020) (Jones, 2004; Petyt et al., 2009; CIS bio international, 2017) (Jones, 2004; CIS bio international, 2006) (Venencia et al., 2002; Jones, 2004) |
| samarium-153 | 1.95 (physical half-life) | – |
| holmium-166 | 1.1 (physical half-life) | Not concerned because the microspheres are considered with no biological elimination |
| lutetium-177: Lutathera® PSMA |
1.0 2.1 |
(Calais et al., 2014; EMA, 2021) (Kurth et al., 2018) |
| erbium-169 | 9.4 (physical half-life) | – |
| rhenium-186 | 3.8 (physical half-life) | – |
| radium-223 | 11.4 (physical half-life) | No reference found in literature. Only the physical half-life was considered, in a conservative approach |
| actinium-225 | 10 (physical half-life) | No reference found in literature. Only the physical half-life was considered, in a conservative approach |
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.